Back |
home / stock / trvi / trvi message board
Subject | By | Source | When |
---|---|---|---|
znewcar1: TRVI 32% v14,3M c1.15 f25,8M H1.59 S1.11 | znewcar1 | investorshangout | 03/02/2022 9:14:34 PM |
znewcar1: TRVI 36% v3,4M c.8711 f25,8M H.8889 mid day flush.627 | znewcar1 | investorshangout | 03/02/2022 3:18:00 AM |
$TRVI, this works! | $oldier Hard | investorshub | 03/01/2022 5:53:32 PM |
$TRVI 5 times it's avg 10 day volume, | $oldier Hard | investorshub | 11/11/2021 6:46:40 PM |
You still here with me? | $oldier Hard | investorshub | 10/25/2021 8:05:06 PM |
I agree. | $oldier Hard | investorshub | 10/14/2021 12:27:24 AM |
Very interesting here. | ttottip | investorshub | 10/13/2021 4:31:48 PM |
znewcar1: TRVI 25% v12,3M,015 1.5000 23,971,730 +22.50% 1.6500 | znewcar1 | investorshangout | 10/11/2021 8:19:11 PM |
Brand new Reddit forum discussion TRVI. | frugalNorwegian | investorshub | 09/04/2021 9:33:52 PM |
TRVI Updated information from the most recent corporate presentation. | Long_Holder | investorshub | 10/06/2020 9:09:51 PM |
UPPPP 13%+ | BioSpecialist | investorshub | 06/03/2020 11:16:35 AM |
RALLYYYYYYYYYYYYYYYYYYYYYYyyy | BioSpecialist | investorshub | 06/01/2020 7:43:14 PM |
Up 7%+ on no volume so once we | BioSpecialist | investorshub | 05/29/2020 11:58:04 AM |
Major breakout to $5+ could start anytime now | BioSpecialist | investorshub | 05/28/2020 4:39:51 PM |
One of the cheapest biotech you can get | BioSpecialist | investorshub | 05/28/2020 1:33:36 PM |
Biofreak: Here is an extremely underpriced (trading under cash) and undiscovered biotech stock : (TR | Biofreak | investorshangout | 05/28/2020 1:23:30 PM |
SmallCapTraders: We are watching a very interesting story right now. Recent acquisition and reverse | SmallCapTraders | investorshangout | 04/15/2020 1:43:13 AM |
News, Short Squeeze, Breakout and More Instantly...
Trevi Therapeutics Inc. Company Name:
TRVI Stock Symbol:
NYSE Market:
Trevi Therapeutics Inc. Website:
Trevi Therapeutics to Participate in Upcoming Conferences PR Newswire NEW HAVEN, Conn. , May 9, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™...
Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates PR Newswire Reaffirms guidance for the Phase 2a RIVER trial in refractory chronic cough and Human Abuse Potential (HAP) Study with topline data for each expected in the second half of...
Trevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 7, 2024 PR Newswire Conference call and webcast to be held at 4:30 p.m. ET NEW HAVEN, Conn. , May 1, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc...